The FDA almost never tests products itself. But in May, JAMA published the results of a randomized trial, conducted by FDA researchers, to determine whether the chemicals in four commercially available sunscreens are absorbed through the skin into the bloodstream

Quick Read

How an obsolete medical device with a security flaw became a must-have for some patients with type 1 diabetes. In 2014, a few hackers realized that the security flaw in certain Medtronic pumps could be exploited for a DIY revolution.

Quick Read

One of the namesakes of the federal “right-to-try” law confirmed Tuesday that he gained access to an experimental treatment thanks to the new law

Quick Read

A version of the club drug is expected to be approved for depression in March. Researchers think it could help treat suicidal thinking

Quick Read

The government shutdown could soon jeopardize highly anticipated new drugs from Janssen, Sanofi and Novartis for depression, diabetes and multiple sclerosis, as well as a host of other potential new therapies, according to a STAT analysis of upcoming regulatory decision dates

Quick Read

The Food and Drug Administration has approved a potent new opioid painkiller, despite warnings from physician critics who say the drug will contribute to the addiction epidemic

Quick Read

The Food and Drug Administration has agreed to consider Sanofi Pasteur’s application for Dengvaxia, the world’s first licensed vaccine that protects against dengue but one that brings with it considerable controversy and concern

Quick Read

In 2016, as the mosquito-borne Zika virus spread through the Americas and cases of infected women having brain-damaged babies mounted, investigators raced to develop a vaccine. Now, a $110 million vaccine trial is underway at 17 sites in nine countries, but it faces an unexpected, and ironic, challenge

Quick Read